Beyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) Benchmark

• URL: http://arxiv.org/abs/2606.30170v1
• Date: Mon, 29 Jun 2026 11:46:48 GMT
• Title: Beyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) Benchmark
• Abstract summary: Generative molecular design is shaped by proxy benchmarks for drug-like properties and models pretrained on large pharmaceutical datasets.<n>We introduce the Nanotechnology Molecular Optimization Benchmark, which bridges machine learning (ML) and quantum materials science.<n>NMO acts simultaneously as a rigorous testbed for the ML community and a discovery engine for nanotechnology research.
• Score: 16.79939279536708
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Generative molecular design is shaped by simple proxy benchmarks for drug-like properties and models pretrained on large pharmaceutical datasets. This combination yields strong benchmark metrics but limits transferability to domains structurally distinct from drug discovery. To overcome this limitation and drive discovery toward real, scientifically grounded targets, we introduce the Nanotechnology Molecular Optimization (NMO) Benchmark, which bridges machine learning (ML) and quantum materials science. NMO acts simultaneously as a rigorous testbed for the ML community and a discovery engine for nanotechnology research. The suite replaces proxy oracles with quantum simulations and introduces strict protocols that prioritize scientific utility over leaderboard-oriented overfitting. The physics-based NMO tasks impose hard structural constraints and rugged fitness landscapes, posing fundamentally new requirements on generative models. Notably, advanced molecular optimization methods underperform much simpler approaches on the NMO tasks. We develop a new baseline method identifying the critical components to solve the NMO tasks, including a novel representation for modeling structural constraints and a domain-agnostic pretraining strategy to eliminate pharmaceutical dataset bias. Our results surpass state-of-the-art physical properties and reveal previously unknown structural motifs, offering new insights for the nanotechnology community and demonstrating that ML can drive genuine scientific discovery.

Related papers

• A Systematic Survey and Benchmark of Deep Learning for Molecular Property Prediction in the Foundation Model Era [57.5440098776759]
  Molecular property prediction integrates quantum chemistry, cheminformatics, and deep learning to connect molecular structure with biological behavior.<n>This survey traces four complementary paradigms, including Quantum, Descriptor Machine Learning, Geometric Deep Learning, and Foundation Models.<n> Benchmark analyses integrate evidence from both widely used datasets and datasets reflecting industry perspectives.
  arXiv  Detail & Related papers  (2026-04-17T15:16:33Z)
• Foundation Models for Discovery and Exploration in Chemical Space [57.97784111110166]
  MIST is a family of molecular foundation models trained on large unlabeled datasets.<n>We demonstrate the ability of these models to solve real-world problems across chemical space.
  arXiv  Detail & Related papers  (2025-10-20T17:56:01Z)
• Combining Graph Neural Networks and Mixed Integer Linear Programming for Molecular Inference under the Two-Layered Model [6.107266553770076]
  We develop a molecular inference framework based on mol-infer, namely mol-infer-GNN, that utilizes GNN as the learning method.<n>Our proposed GNN model can obtain satisfying learning performances for some properties despite its simple structure.
  arXiv  Detail & Related papers  (2025-07-05T06:57:37Z)
• A Comprehensive Benchmarking Platform for Deep Generative Models in Molecular Design [0.0]
  Deep generative models have emerged as promising tools for accelerating drug discovery by efficiently exploring the vast chemical space.<n>This research presents an analysis of the Molecular Sets (MOSES) platform, a comprehensive benchmarking framework designed to standardize evaluation of deep generative models in molecular design.<n>Our findings reveal that different architectures exhibit complementary strengths across various metrics, highlighting the complex trade-offs between exploration and exploitation in chemical space.
  arXiv  Detail & Related papers  (2025-05-19T08:34:38Z)
• Pretraining Generative Flow Networks with Inexpensive Rewards for Molecular Graph Generation [6.495442425890008]
  We introduce Atomic GFlowNets (A-GFNs), a generative model leveraging individual atoms as building blocks to explore drug-like chemical space more comprehensively.<n>We propose an unsupervised pre-training approach using drug-like molecule datasets, which teaches A-GFNs about inexpensive yet informative molecular descriptors.<n>In this work, we pretrain A-GFN on a subset of ZINC dataset, and by employing robust evaluation metrics we show the effectiveness of our approach.
  arXiv  Detail & Related papers  (2025-03-08T20:41:07Z)
• GFlowNet Pretraining with Inexpensive Rewards [2.924067540644439]
  We introduce Atomic GFlowNets (A-GFNs), a foundational generative model leveraging individual atoms as building blocks to explore drug-like chemical space more comprehensively. We propose an unsupervised pre-training approach using offline drug-like molecule datasets, which conditions A-GFNs on inexpensive yet informative molecular descriptors. We further our method by implementing a goal-conditioned fine-tuning process, which adapts A-GFNs to optimize for specific target properties.
  arXiv  Detail & Related papers  (2024-09-15T11:42:17Z)
• Retrieval-based Controllable Molecule Generation [63.44583084888342]
  We propose a new retrieval-based framework for controllable molecule generation. We use a small set of molecules to steer the pre-trained generative model towards synthesizing molecules that satisfy the given design criteria. Our approach is agnostic to the choice of generative models and requires no task-specific fine-tuning.
  arXiv  Detail & Related papers  (2022-08-23T17:01:16Z)
• Accurate Machine Learned Quantum-Mechanical Force Fields for Biomolecular Simulations [51.68332623405432]
  Molecular dynamics (MD) simulations allow atomistic insights into chemical and biological processes. Recently, machine learned force fields (MLFFs) emerged as an alternative means to execute MD simulations. This work proposes a general approach to constructing accurate MLFFs for large-scale molecular simulations.
  arXiv  Detail & Related papers  (2022-05-17T13:08:28Z)
• Improving Molecular Representation Learning with Metric Learning-enhanced Optimal Transport [49.237577649802034]
  We develop a novel optimal transport-based algorithm termed MROT to enhance their generalization capability for molecular regression problems. MROT significantly outperforms state-of-the-art models, showing promising potential in accelerating the discovery of new substances.
  arXiv  Detail & Related papers  (2022-02-13T04:56:18Z)
• Hybrid quantum-classical machine learning for generative chemistry and drug design [0.0]
  We build a compact discrete variational autoencoder with a Boltzmann Machine (RBM) of reduced size in its latent layer. We generate 2331 novel chemical structures with medicinal chemistry and synthetic accessibility properties. Results demonstrate the feasibility of using already existing or soon-to-be-available quantum computing devices as testbeds for future drug discovery applications.
  arXiv  Detail & Related papers  (2021-08-26T08:23:32Z)
• Machine Learning in Nano-Scale Biomedical Engineering [77.75587007080894]
  We review the existing research regarding the use of machine learning in nano-scale biomedical engineering. The main challenges that can be formulated as ML problems are classified into the three main categories. For each of the presented methodologies, special emphasis is given to its principles, applications, and limitations.
  arXiv  Detail & Related papers  (2020-08-05T15:45:54Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.